Regional Epidemiology Of Hypertension

In The Gulf

Jafar Al-Said, MB. CHB. MD. FASN. FACP.Chair of Internal Medicine.

Nephrology and Internal Medicine Consultant.Bahrain Specialist Hospital.

1

LEARNING OBJECTIVES

• Prevalence of HTN in the Gulf region.

• Global Prevalence of HTN.

• Expected Population Growth for the coming decades.

• Health impact of other CV risk factors.

• Impact of HTN by WHO for the coming decades.

2

HTN PREVALENCE IN THE GULF

3

800%

4

UAE

9,206,000

HTN 19.1%

Yaman

23,852,000

HTN

25.1%

Bahrain

1,318,000

HTN 28%

Kuwait

3,250,000

HTN

20%

KSA

28,288,000

HTN 25.2%

Is. Rep.I

ran

76,424,000

HTN 24.3%

Iraq

32,778,000

HTN

24.4%

3,314,000

HTN 25.4%

WHO 2014 ANNUAL REPORT

TOTAL POPULATION

180,481,000

HTN 24% 45,120,250

Qatar

2,051,000

HTN 25%

5

ARE WE READY TO TREAT

45,120, 250 X 2 = ???

HTN PATIENT IN 2050

90,240,5006

GLOBAL PREVALENCE OF HYPERTENSION

7

WHO REGIONAL OFFICES HTN PREVALENCE

45%

35%

41%

41% 36%

38%

HTN GLOBAL

PREVALENCE

39%

8

9

POPULATION GROWTH

10

11

Global HTN PATEINTS

39% = 2,822,891,760

12

WORLD POPULATION ESTIMATES FROM 1800 TO 2100, BASED ON "HIGH", "MEDIUM" AND "LOW"

UNITED NATIONS PROJECTIONS IN 2010[[FILE:WORLD-POPULATION-1800-2100.SVG|THUMB|WORLD-POPULATION-1800-

2100]]

13

14

GLOBAL PREVALENCE OF HTN IN 2100

40% of the Global population:

High UN estimated HTN

16 billion 6.4 billion

Low UN estimated

10 billion 4 billion

15

DIABETES STATISTICS

16

DIABETES PREVALENCE 2013

17

GLOBAL DIABETES PATIENTS

Year 2000 2030

DM 171,000,000

366,000,000

WHO | Country and regional data on diabetes18

19

DM Population in the Gulf Region 2000-2030

2000 2030

4,630,000 13,772, 000

37,000

2,103,000

668,000

104,000 113,000 38,000

890,000

350,000 327,000

0

1,000,000

2,000,000

3,000,000

4,000,000

5,000,000

6,000,000

7,000,000

Bahrain Islamic

Republic of

Iran

Iraq Kuwait Oman Qatar Saudi

Arabia

United

Arab

Emirates

Yemen

Chart Title

2000 2030

Global DM Prevalence

20

OBESITY

21

23

HYPERLIPIDEMIA

24

25

Global 39%

Males 37%

Females 40%

CORONARY ARTERY DISEASE

26

CAUSES OF INCREASED HYPERTENSION %

28

29

30

31

32

33

34

35

36

80% of death from CVD occur in lower and middle income countries.

37

Mortality rates of cardiovascular diseases in

high-income and low-income Countries (age

standardized, 2008

Causes of death 2008, [Online Database]. Geneva, WHO

2013.

38

39

ARE WE READY ????

CONCUSION AND RECOMMENDATION

• HTN effect about 25% of the Gulf Population.

• It is effecting 40% of the population around the world.

• HTN out weight all the other cardiovascular risk factors.

• Major efforts should be spent in awareness, prevention and eventually

management.

• This was the main aim behind organizing this conference. 40

REFERENCES

WHO Library Cataloguing-in-Publication Data Global status report on noncommunicable diseases2010. 1.Chronic disease - prevention and control. 2.Chronic disease - epidemiology. 3.Chronic disease- mortality. 4.Cost of illness. 5.Delivery of health care.. I.World Health Organization. ISBN 978 92 4156422 9 (NLM classification: WT 500). ISBN 978 92 4 068645 8 (PDF).

Joffres M, Falaschetti E, Gillespie C, et al. Hypertension prevalence, awareness, treatment and

control in national surveys from England, the USA and Canada, and correlation with stroke and

ischemic heart disease mortality: a cross-sectional study BMJ Open 2013;3:e003423.

doi:10.1136/bmjopen-2013-003423.

A global brief on Hypertension. Document number : WHO/DCO/WHD/2013.2. Any queries regarding

this document should be addressed to : communications@who.int.

World Health Organization - Noncommunicable Diseases (NCD) Country Profiles, 2014.

41